Moderna Chief Medical Officer Dr. Paul Burton acknowledges while governments are trying to protect health care systems, COVID restrictions over omicron are making people anxious.. fell after the company lowered its sales guidance for 2022 and missed revenue expectations for the third quarter.
Previously, the COVID-19 vaccine maker estimated end-of-year revenue would land at $21 billion. But, on Thursday, it changed those expectations to between $18 and $19 billion. Syringes sit in front of a Moderna logo in this illustration from Nov. 27, 2021. Overall third-quarter net income for Moderna stands at $1.043 billion, down from $3.333 billion, or $7.70 a share, from the prior year. Revenue also fell from $4.9 billion to $3.3 billion by the end of September. Moderna's shares declined in early morning trading Thursday after the company released poor third-quarter earnings.
"Today's earnings continue to show strong corporate momentum," Stéphane Bancel, Moderna's CEO, said in a statement to investors. "With $13.
poison
Couldn't happen to a better group of deceitful b*stards!
Delighted
Because it doesn’t prevent nor prevent the transmission of Covid.
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
منبع: cnni - 🏆 326. / 59 ادامه مطلب »